Xia Y, Wu Q, Wang H, Zhang S, Jiang Y, Gong T, et al. Global, regional and national burden of gout, 1990–2017: a systematic analysis of the Global Burden of Disease Study. Rheumatology (Oxford). 2020;59(7):1529–38.

Article  CAS  PubMed  Google Scholar 

He Q, Mok TN, Sin TH, Yin J, Li S, Yin Y, et al. Global, regional, and national prevalence of gout from 1990 to 2019: age-period-cohort analysis with future burden prediction. JMIR Public Health Surveill. 2023;9: e45943.

Article  PubMed  PubMed Central  Google Scholar 

Jeong YJ, Park S, Yon DK, Lee SW, Tizaoui K, Koyanagi A, et al. Global burden of gout in 1990–2019: a systematic analysis of the Global Burden of Disease study 2019. Eur J Clin Invest. 2023;53(4): e13937.

Article  PubMed  Google Scholar 

Tang YM, Zhang L, Zhu SZ, Pan JJ, Zhou SH, He TJ, et al. Gout in China, 1990–2017: the global burden of disease study 2017. Public Health. 2021;191:33–8.

Article  CAS  PubMed  Google Scholar 

Zhu B, Wang Y, Zhou W, Jin S, Shen Z, Zhang H, et al. Trend dynamics of gout prevalence among the Chinese population, 1990–2019: a joinpoint and age-period-cohort analysis. Front Public Health. 2022;10:1008598.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Jin C, Ma B, Sun H, Chen Y, Zhong Y, et al. Global, regional and national burdens of gout in the young population from 1990 to 2019: a population-based study. RMD Open. 2023;9(2): e003025.

Article  PubMed  PubMed Central  Google Scholar 

Xie Y, Xu P, Liu K, Lin S, Wang M, Tian T, et al. Hyperuricemia and gout are associated with cancer incidence and mortality: a meta-analysis based on cohort studies. J Cell Physiol. 2019;234(8):14364–76.

Article  CAS  PubMed  Google Scholar 

Lottmann K, Chen X, Schädlich PK. Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Curr Rheumatol Rep. 2012;14(2):195–203.

Article  PubMed  PubMed Central  Google Scholar 

Liu K, Yao Y, Chen W, Mao Y, Ye D, Wen C. Modifiable risk factors and incidence of gout: estimation of population attributable fraction in the US. Semin Arthritis Rheum. 2022;55: 152040.

Article  PubMed  Google Scholar 

Safiri S, Kolahi AA, Cross M, Carson-Chahhoud K, Hoy D, Almasi-Hashiani A, et al. Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990–2017: a systematic analysis of the global burden of disease study 2017. Arthritis Rheumatol. 2020;72(11):1916–27.

Article  CAS  PubMed  Google Scholar 

Amiri F, Kolahi AA, Nejadghaderi SA, Noori M, Khabbazi A, Sullman MJM, et al. The burden of gout and its attributable risk factors in the Middle East and North Africa region, 1990 to 2019. J Rheumatol. 2023;50(1):107–16.

Article  PubMed  Google Scholar 

Liu YR, Wang JQ, Li J. Role of NLRP3 in the pathogenesis and treatment of gout arthritis. Front Immunol. 2023;14:1137822.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajab IM, Hart PC, Potempa LA. How C-reactive protein structural isoforms with distinctive bioactivities affect disease progression. Front Immunol. 2020;11:2126.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boncler M, Wu Y, Watala C. The multiple faces of C-reactive protein-physiological and pathophysiological implications in cardiovascular disease. Molecules. 2019;24(11):2062.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuppa A, Tripathi H, Al-Darraji A, Tarhuni WM, Abdel-Latif A. C-reactive protein levels and risk of cardiovascular diseases: a two-sample bidirectional Mendelian randomization study. Int J Mol Sci. 2023;24(11):9129.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu Y, Sun S, Huang Y, Gao Q, Xie X, Wang P, et al. Metagenomic analysis revealed the potential role of gut microbiome in gout. NPJ Biofilms Microbiomes. 2021;7(1):66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alduraibi FK, Saleem M, Ricart K, Patel RP, Szalai AJ, Singh JA. Clustering patients with gout based on comorbidities and biomarkers: a cross-sectional study. J Rheumatol. 2023;50(6):817–26.

Article  CAS  PubMed  Google Scholar 

Maluf CB, Barreto SM, Giatti L, Ribeiro AL, Vidigal PG, Azevedo DRM, et al. Association between C reactive protein and all-cause mortality in the ELSA-Brasil cohort. J Epidemiol Community Health. 2020;74(5):421–7.

Article  PubMed  Google Scholar 

Wanner C, Metzger T. C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant. 2002;17(Suppl 8):29–40.

Article  CAS  PubMed  Google Scholar 

Sung KC, Ryu S, Chang Y, Byrne CD, Kim SH. C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians. Eur Heart J. 2014;35(27):1809–16.

Article  CAS  PubMed  Google Scholar 

Rider BC, Bassett DR, Strohacker K, Overstreet BS, Fitzhugh EC, Raynor HA. Psycho-physiological effects of television viewing during exercise. J Sports Sci Med. 2016;15(3):524–31.

PubMed  PubMed Central  Google Scholar 

Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in Hypertension. 2018 Jun;71(6):e140–e144]. Hypertension. 2018;71(6):e13-115.

CAS  PubMed  Google Scholar 

American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Suppl 1):S13-28.

Article  Google Scholar 

Pope JE, Choy EH. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheum. 2021;51(1):219–29.

Article  CAS  PubMed  Google Scholar 

Melnikov I, Kozlov S, Saburova O, Avtaeva Y, Guria K, Gabbasov Z. Monomeric C-reactive protein in atherosclerotic cardiovascular disease: advances and perspectives. Int J Mol Sci. 2023;24(3):2079.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pravenec M, Kajiya T, Zídek V, Landa V, Mlejnek P, Simáková M, et al. Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome. Hypertension. 2011;57(4):731–7.

Article  CAS  PubMed  Google Scholar 

Tice JA, Browner W, Tracy RP, Cummings SR. The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women. Am J Med. 2003;114(3):199–205.

Article  CAS  PubMed  Google Scholar 

Liu Y, Yang D, Shi F, Wang F, Liu X, Wen H, et al. Association of serum 25(OH)D, cadmium, CRP with all-cause, cause-specific mortality: a prospective cohort study. Front Nutr. 2022;9: 803985.

Article  PubMed  PubMed Central  Google Scholar 

Xia M, Zhang C, Gu J, Chen J, Wang LC, Lu Y, et al. Impact of C-reactive protein on long-term mortality in acute myocardial infarction patients with diabetes and those without. Clin Chim Acta. 2018;480:220–4.

Article  CAS  PubMed  Google Scholar 

Tian R, Tian M, Wang L, Qian H, Zhang S, Pang H, et al. C-reactive protein for predicting cardiovascular and all-cause mortality in type 2 diabetic patients: a meta-analysis. Cytokine. 2019;117:59–64.

Article  CAS  PubMed